ArticleJournal of hepatocellular carcinoma2026
Clinical Efficacy Exploration of Temperature-Sensitive Embolic Agent TACE Combined with HAIC and Targeted/Immunotherapy for Unresectable Primary Liver Cancer.
Xingyu Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.